Email Alert | RSS    帮助

中国防痨杂志 ›› 2024, Vol. 46 ›› Issue (6): 648-653.doi: 10.19982/j.issn.1000-6621.20240084

• 论著 • 上一篇    下一篇

QuantiFERON-TB Gold Plus与QuantiFERON-TB Gold In-Tube 在骨关节结核辅助诊断中的比较研究

贾红彦, 范俊, 孙琦, 宋瑞雪, 杜博平, 董静, 王颖超, 邢爱英, 朱传智, 李自慧, 潘丽萍()   

  1. 耐药结核病研究北京市重点实验室/首都医科大学附属北京胸科医院/北京市结核病胸部肿瘤研究所,北京 101149
  • 收稿日期:2024-03-07 出版日期:2024-06-10 发布日期:2024-06-03
  • 通信作者: 潘丽萍,Email:panliping2006@163.com
  • 作者简介:注:范俊与贾红彦对本文具有同等贡献,为并列第一作者
  • 基金资助:
    北京市自然科学基金(L234055);通州区科技计划项目(KJ2022CX042);北京市医院管理中心青年职工创新工作室-创新梦工场(202136);通州区运河计划人才项目(YH202001)

Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis

Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping()   

  1. Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
  • Received:2024-03-07 Online:2024-06-10 Published:2024-06-03
  • Contact: Pan Liping, Email:panliping2006@163.com
  • Supported by:
    Beijing Natural Science Foundation(L234055);Tongzhou Science and Technology Project(KJ2022CX042);Beijing Hospitals Authority Innovation Studio of Young Staff Funding Support(202136);Tongzhou Yunhe Project(YH202001)

摘要:

目的: 评价QuantiFERON-TB Gold Plus(简称“QFT-Plus”)和QuantiFERON-TB Gold In-Tube(简称“QFT-GIT”)检测辅助诊断骨关节结核的应用价值及其检测结果的一致性。方法: 选取2023年4—9月于首都医科大学附属北京胸科医院就诊的骨关节结核患者88例作为观察组,非结核性骨关节疾病患者123例作为对照组。所有研究对象同时行外周血QFT-Plus和QFT-GIT检测。分析QFT-Plus和QFT-GIT辅助诊断骨关节结核的价值,评价两种方法检测结果的一致性。结果: 211例研究对象中,剔除4例检测为不确定结果者,最终将207例研究对象检测结果纳入诊断性能评估(观察组86例,对照组121例)。QFT-Plus检测的敏感度为95.3%(95%CI:87.9%~98.5%),特异度为70.2%(95%CI:61.2%~78.0%),阳性预测值为65.5%(95%CI:60.2%~77.5%),阴性预测值为95.5%(95%CI:88.3%~98.6%);QFT-GIT检测的敏感度为91.9%(95%CI:83.4%~96.4%),特异度为66.9%(95%CI:57.7%~75.1%),阳性预测值为66.4%(95%CI:57.1%~74.6%),阴性预测值为92.0%(95%CI:83.8%~96.5%)。QFT-Plus和QFT-GIT检测结果的总一致率为91.8%(95%CI:88.1%~95.5%),阳性一致率为92.4%(95%CI:87.7%~97.2%),阴性一致率为90.9%(95%CI:84.9%~96.9%),一致性检验Kappa值为0.832(95%CI:0.756~0.908,P<0.001)。结论: QFT-Plus与QFT-GIT检测结果具有良好的一致性,在骨关节结核诊断中具有相似的辅助诊断效能。

关键词: 结核,骨关节, 诊断,鉴别, 免疫学试验, 评价研究

Abstract:

Objective: To assess the utility and concordance of QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON-TB Gold In-Tube (QFT-GIT) assays in the adjunctive diagnosis of osteoarticular tuberculosis. Methods: Between April and September 2023, 88 patients diagnosed with osteoarticular tuberculosis at the Beijing Chest Hospital, affiliated with Capital Medical University, were enrolled as the observation group, while 123 individuals presenting with non-tuberculous osteoarticular conditions comprised the control group. Each participant underwent concurrent peripheral blood assays using both the QFT-Plus and QFT-GIT. This study evaluated the diagnostic utility and result concordance of the two tests in aiding the diagnosis of osteoarticular tuberculosis. Results: Of the 211 initial participants, 4 were excluded due to indeterminate results, leaving 207 subjects for analysis (86 in the observation group and 121 in the control). The QFT-Plus assay demonstrated a sensitivity of 95.3% (95%CI: 87.9%-98.5%), specificity of 70.2% (95%CI: 61.2%-78.0%), positive predictive value of 65.5% (95%CI: 60.2%-77.5%), and negative predictive value of 95.5% (95%CI: 88.3%-98.6%). The QFT-GIT assay recorded a sensitivity of 91.9% (95%CI: 83.4%-96.4%), specificity of 66.9% (95%CI: 57.7%-75.1%), positive predictive value of 66.4% (95%CI: 57.1%-74.6%), and negative predictive value of 92.0% (95%CI: 83.8%-96.5%). The overall concordance between QFT-Plus and QFT-GIT results was 91.8% (95%CI: 88.1%-95.5%), with a positive agreement of 92.4% (95%CI: 87.7%-97.2%) and a negative agreement of 90.9% (95%CI: 84.9%-96.9%). The Kappa coefficient for agreement was 0.832 (95%CI: 0.756-0.908, P<0.001). Conclusion: The QFT-Plus and QFT-GIT assays demonstrated substantial concordance and comparable diagnostic efficacy in the auxiliary evaluation of osteoarticular tuberculosis.

Key words: Tuberculosis, osteoarticular, Diagnosis, differential, Immunologic tests, Evaluation studies

中图分类号: